“Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, International Journal of Advances in Science, Engineering and Technology (IJASEAT), Volume 7, Issue-3, pp. 77-82, 2019 http://www.iraj.in/journal/journal_file/journal_pdf/6-580-157129166377-82.pdf (JIF: 3.15)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalDefault journal
StatePublished - 2019

Fingerprint Dive into the research topics of '“Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, International Journal of Advances in Science, Engineering and Technology (IJASEAT), Volume 7, Issue-3, pp. 77-82, 2019 http://www.iraj.in/journal/journal_file/journal_pdf/6-580-157129166377-82.pdf (JIF: 3.15)'. Together they form a unique fingerprint.

Cite this